I do like crayons.
I will use the few that I haven’t ingested to draw smiley faces and love hearts on your reply.
please draw (with crayon ideally) my attention to where I said that I “don’t think they have some questions to be asked of them”
Please further explain what benefit it is for a company to drive a 1 week long pump and dump of its own stock?
Is it beneficial for a company to be perceived as being a pump and dump stock?
Does it help with long-term price climb to improve their credit raising ability? In January according to your estimates (despite them saying they won’t need to until a bit later in the year)
Thank you for drawing attention to me being an investor who smiles when I am fooled. If you look more closely you’ll realise the smile is drawn on, a la Joker, with nothing other than, yep you guessed it, crayon.
Look even more closely, inside this time, and you’ll realise that you don’t know enough about me or my approach to investing in 4DS to make assertions about me.
this recent price action was clearly a pump and dump. I haven’t denied that.
In fact I was lucky enough to enact a trade and make a tidy profit. I didn’t buy at the lowest price and I didn’t sell at the highest that it reached, but I carried home more than one bag and of a size that I’m quite happy with.
So I am smiling, but not because I was fooled.
I cross my fingers that the high risk speculative play that is holding long term eventually proves successful.
In the meantime, feel free to stick to your constructive points as there is benefit to them, but perhaps ease off on the tone of delivery and the casting of aspersions.
yours sincerely
Dr Crayon
- Forums
- ASX - By Stock
- 4DS
- 4DS - Anything but Charting
4DS - Anything but Charting, page-25729
-
- There are more pages in this discussion • 4,991 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
|
|||||
Last
8.8¢ |
Change
-0.002(2.22%) |
Mkt cap ! $155.1M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 8.8¢ | $255.0K | 2.855M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 201205 | 0.088 |
8 | 774567 | 0.087 |
5 | 576804 | 0.086 |
13 | 1368456 | 0.085 |
2 | 220000 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 20000 | 1 |
0.090 | 313381 | 2 |
0.091 | 11445 | 1 |
0.092 | 683892 | 3 |
0.093 | 181179 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online